The US National Institute of Health granted BTA with $5.6 for phase III Western Trials of LANI. I would not be suprised that NIH would be privy to all Japan phase III test data as a condition of this funding. Therefore, i would think, in an exacerbation of the swine flu or another mutation pandemic situation, Phase III for US FDA approval may be given using the 'emergency' provisions and based on the Japanese Phase III trial data, i.e. no Phase III for US. Under these circumstances LANI would hit the US and world markets a lot sooner than Naira indicates. I could be wrong but i could be right.
- Forums
- ASX - By Stock
- BTA
- danger, will robinson
danger, will robinson, page-6
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online